Final results from the phase 3 randomized, open-label ADMIRAL trial (ClinicalTrials.gov Identifier: NCT02421939) showed significantly improved overall survival ...
54859 items (54859 unread) in 74 feeds
Final results from the phase 3 randomized, open-label ADMIRAL trial (ClinicalTrials.gov Identifier: NCT02421939) showed significantly improved overall survival ...